New technique builds microscopic medical devices for transplants

August 30, 1999

COLUMBUS, Ohio -- The same technology that creates computer microchips may one day help treat diseases such as diabetes, according to an Ohio State University researcher.

Mauro Ferrari, professor of biomedical engineering at Ohio State, has devised a method for implanting tiny silicon capsules -- about the size of a pinhead -- beneath a patient's skin. Such capsules would carry healthy transplant cells that would take the place of the patient's malfunctioning cells by producing needed chemicals for the body. For example, capsules in diabetics could allow patients to produce insulin again, Ferrari explained.

Today, doctors suppress patients' immune systems with drugs to keep antibodies from destroying transplanted tissue, leaving patients open to infections. Ferrari's technique eliminates the need for immunosuppression, and for transplanting an entire organ when a few grams of healthy cells will do.

"If you can't beat the immune system, you hide from it," said Ferrari. He and his colleagues are working to nanomachine capsules with holes that are just the right size -- big enough to let the needed chemicals get out, but small enough to keep the antibodies from getting in.

In their latest study, Ferrari and his colleagues were able to create 2-millimeter capsules, each containing millions of channels only 18 nanometers -- approximately 50 atoms -- across.

The researchers simulated the capsule's use in treating insulin-dependent diabetes. The 18-nanometer holes allowed glucose and insulin molecules to pass through, but blocked the antibody immunoglobulin G (IgG), which attacks transplanted cells.

These results were published in a recent issue of the Journal of Membrane Science. Ferrari began this work before he became director of Ohio State's Biomedical Engineering Center, while still on the faculty of the University of California at Berkeley. He is continuing the work at Ohio State. Co-authors Tejal Desai and Derek Hansford are former students of his at Berkeley; Desai is now assistant professor of Bioengineering at the University of Illinois at Chicago, and Hansford joined the Ohio State faculty as an assistant professor of biomedical engineering in August 1999.

Other researchers have tried to construct similar capsules from plastic, but the materials were incompatible with the body, and couldn't provide immunoisolation for a sufficiently long period of time, Ferrari explained. He and his colleagues chose silicon because it wouldn't react with the body, and because the computer industry had already developed methods for creating precise surface features with the material.

Ferrari's patented method employs photolithography, a technique in which microchip manufacturers take a smooth layer of silicon atoms and eat away portions of the surface with chemicals. The holes that result are all the same size, down to an atom. "If we want to make 18-nanometer holes, we make 18-nanometer holes," said Ferrari, "millions and millions of them, all exactly the same."

Insulin-dependent diabetes develops when the body fails to recognize cells in the pancreas that respond to glucose and produce insulin. One possible therapy is to transplant even just a few grams of healthy pancreatic cells, Ferrari explained. A capsule containing the cells could be inserted under the skin anywhere in the body. Molecules of glucose would enter the capsule, and the transplanted cells would release insulin, which would flow back out.

Determining the right hole diameter was difficult, Ferrari said, because nobody knows the size of these molecules for sure. Initial tests revealed that both insulin and glucose could pass, though with difficulty, through 18-nanometer holes.

Ferrari and his colleagues then inserted a silicon membrane containing 18-nanometer holes between two chambers of liquid, one containing IgG. Over the next four days, they measured the amount of IgG that penetrated the membrane.

After one day, the concentration of IgG in the second chamber was less than 0.4 percent. After four days, the concentration had grown to just over 1 percent.

Ferrari characterized this rate as several times slower than capsules made of plastic. He cited a similar study in which a perforated plastic membrane allowed an IgG concentration of 1 percent to accumulate in the second chamber after only 24 hours.

He added that keeping out 100 percent of all IgG may be impossible. Researchers think the molecule is not spherical, and if it enters an opening with its narrow end, it can squeeze through. "These molecules twist and turn and find their way into small passageways -- that's what makes them good antibodies," said Ferrari.

As to cost, Ferrari said that one capsule could produce all the insulin a patient needed for a year for about $20. He hopes to be able to test his capsules in clinical trials within the next three years.

Ferrari and his colleagues recently received a $1.4 million grant from the State of Ohio Board of Regents to continue this work in a consortium. Member institutions include Ohio State, Case Western Reserve University, University of Cincinnati, University of Akron, the Cleveland Clinic Foundation, and the Battelle Memorial Institute.
-end-


Ohio State University

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.